Supplementary Figure 2 from Afatinib Prolongs Survival Compared with Gefitinib in an Epidermal Growth Factor Receptor-Driven Lung Cancer Model

PDF File - 320K, CT images of lungs from transgenic mice with Egfr exon 19 deletion mutation pretreatment (day 0), after 1 week and 4 weeks administration of vehicle or gefitinib (5mg/kg/day) or afatinib (5mg/kg/day).